Sensus Healthcare, Inc.
SRTS
$3.92
-$0.09-2.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -34.26% | -13.80% | 3.29% | 24.74% | 71.30% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -34.26% | -13.80% | 3.29% | 24.74% | 71.30% |
| Cost of Revenue | -10.13% | 14.74% | 24.19% | 38.32% | 67.97% |
| Gross Profit | -51.43% | -32.12% | -10.51% | 15.82% | 73.75% |
| SG&A Expenses | 18.72% | 52.29% | 47.62% | 34.67% | 12.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.07% | 39.75% | 39.96% | 40.89% | 36.01% |
| Operating Income | -227.39% | -145.49% | -116.00% | -53.01% | 2,206.77% |
| Income Before Tax | -206.67% | -136.32% | -105.17% | -46.36% | 1,285.87% |
| Income Tax Expenses | -180.21% | -146.88% | -87.62% | -7.63% | 1,330.72% |
| Earnings from Continuing Operations | -216.13% | -132.28% | -112.76% | -61.29% | 1,270.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -216.13% | -132.28% | -112.76% | -61.29% | 1,270.52% |
| EBIT | -227.39% | -145.49% | -116.00% | -53.01% | 2,206.77% |
| EBITDA | -219.10% | -141.67% | -111.91% | -50.79% | 7,741.28% |
| EPS Basic | -216.00% | -132.21% | -112.72% | -61.32% | 1,281.36% |
| Normalized Basic EPS | -206.63% | -136.27% | -105.20% | -46.09% | 1,389.66% |
| EPS Diluted | -218.46% | -133.30% | -114.46% | -63.67% | 1,493.28% |
| Normalized Diluted EPS | -206.87% | -136.38% | -105.34% | -46.36% | 1,386.21% |
| Average Basic Shares Outstanding | 0.09% | 0.20% | 0.28% | 0.32% | 0.33% |
| Average Diluted Shares Outstanding | -0.20% | 0.24% | 0.39% | 0.54% | 0.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |